Brief: Takara Bio Selects AGC Biologics As Manufacturer Of Plasmid DNA Intermediate For A Vaccine Against COVID-19

Takara Bio

21/05/2020 07:08

May 21 (Reuters) - AGC Biologics:
    * TAKARA BIO SELECTS AGC BIOLOGICS AS MANUFACTURER OF
PLASMID DNA
INTERMEDIATE FOR A VACCINE AGAINST COVID-19 (SARS-COV-2)
    * AGC BIOLOGICS - PARTNERSHIP WITH TAKARA BIO BY
COLLABORATING ON
PROPHYLAXIS DNA VACCINE, WITH AGC MANUFACTURING PLASMID DNA
INTERMEDIATE FOR VACCINE

Source text for Eikon:  ID:nPn3GNT6Ra 
Further company coverage:  4974.T 

 ((Reuters.Briefs@thomsonreuters.com;))